Abstract
New cancer immunotherapeutic strategies rely on recent advances in the knowledge of the mechanisms responsible for antitumor immunity. Immune parameters in humans show temporal variations related to circadian changes of total lymphocytes and specific lymphocyte subsets in the peripheral blood, with an inverse relationship of the total number of lymphocytes to plasma cortisol concentration and a direct correlation to plasma melatonin levels. Immune responses are characterized by nyctohemeral variations and are physiologically controlled by neuroendocrine pathways. The discoveries of the antitumor cytokine network underlay innovative anticancer immunotherapeutic approach, taking into account neuroendocrine and neuroimmune status of cancer patients. Lung cancer patients present anomalies of proportions and circadian variations of lymphocyte subsets, as well as of hormones and cytokines that may impair the interplay among different lymphocyte subpopulations and neuroendocrine system components, decisive for an efficient immune response. A chronobiologic strategy of correctly timed circadian stage-dependent sampling and/or dosing schedule taking in consideration circadian rhythmicity in biochemical, physiological, and behavioral processes will be critical in any attempts to successfully optimize and personalize decision-making when evaluating immunomodulatory effects determined by biological response modifiers and adoptive immunotherapy protocols, in addition to neuroendocrine endogenous molecules, such as the pineal indole melatonin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CCL20:
-
Chemokine (C–C motif) ligand 20
- CCR6:
-
Chemokine (C–C motif) receptor 6
- CTLA-4:
-
Cytotoxic T-lymphocyte antigen 4
- EGF:
-
Epidermal growth factor
- Foxp3:
-
Forkhead transcription factors
- GH:
-
Growth hormone
- GITR:
-
Glucocorticoid-induced TNF-α receptor
- GVHD:
-
Graft-versus-host disease
- HSCT:
-
Hematopoietic stem cell transplantation
- IFN:
-
Interferon
- IGF:
-
Insulin-like growth factor
- IL:
-
Interleukin
- LAK:
-
Lymphokine-activated killer cells
- MHC:
-
Major histocompatibility complex
- MLT-R:
-
Melatonin receptors
- NAT:
-
N-acetyl-transferase
- NK:
-
Natural killer
- PD-1:
-
Programmed death-1
- PKC:
-
Protein kinase C
- TCR:
-
T-cell receptors
- TNF:
-
Tumor necrosis factor
- TRH:
-
Thyrotropin-releasing hormone
- TSH:
-
Thyroid-stimulating hormone
References
Lissoni P, Rovelli F. Principles of psychoneuroendocrinoimmunotherapy of cancer. Immunotherapy. 2012;4(1):77–86.
Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature. 2002;418(6901):935–41.
Mazzoccoli G. The timing clockwork of life. J Biol Regul Homeost Agents. 2011;25(1):137–43.
Mazzoccoli G, Giuliani F, Sothern RB. A method to evaluate dynamics and periodicity of hormone secretion. J Biol Regul Homeost Agents. 2011;25(2):231–8.
Lambert C, Ibrahim M, Iobagiu C, Genin C. Significance of unconventional peripheral CD4+CD8dim T cell subsets. J Clin Immunol. 2005;25:418–27.
Matis LA, Cron R, Bluestone JA. Major histocompatibility complex-linked specificity of gamma delta receptor-bearing T lymphocytes. Nature. 1987;330:262–4.
Matis LA, Bluestone JA. Specificity of gamma delta receptor bearing T cells. Semin Immunol. 1991;3:75–80.
Pelegrí C, Vilaplana J, Castellote C, Rabanal M, Franch A, Castell M. Circadian rhythms in surface molecules of rat blood lymphocytes. Am J Physiol Cell Physiol. 2003;284:C67–76.
Suzuki S, Toyabe S, Moroda T, Tada T, Tsukahara A, Iiai T, Minagawa M, Maruyama S, Hatakeyama K, Endoh K, Abo T. Circadian rhythm of leucocytes and lymphocytes subsets and its possible correlation with the function of the autonomic nervous system. Clin Exp Immunol. 1997;110(3):500–8.
Mazzoccoli G, Bianco G, Correra M, Carella AM, Balzanelli M, Giuliani A, Tarquini R. Circadian variation of lymphocyte subsets in healthy subjects. Recenti Prog Med. 1998;89(11):569–72.
Mazzoccoli G, Correra M, Bianco G, De Cata A, Balzanelli M, Giuliani A, Tarquini R. Age-related changes of neuro-endocrine-immune interactions in healthy humans. J Biol Regul Homeost Agents. 1997;11(4):143–7.
Arjona A, Boyadjieva N, Sarkar DK. Circadian rhythms of granzyme B, perforin, IFN-gamma, and NK cell cytolytic activity in the spleen: effects of chronic ethanol. J Immunol. 2004;172:2811–7.
Arjona A, Sarkar DK. Circadian oscillations of clock genes, cytolytic factors, and cytokines in rat NK cells. J Immunol. 2005;174:7618–24.
Arjona A, Sarkar DK. Are circadian rhythms the code of hypothalamic-immune communication? Insights from natural killer cells. Neurochem Res. 2008;33(4):708–18.
Mazzoccoli G, Sothern RB, De Cata A, Giuliani F, Fontana A, Copetti M, Pellegrini F, Tarquini R. A timetable of 24-hour patterns for human lymphocyte subpopulations. J Biol Regul Homeost Agents. 2011;25(3):387–95.
Maasho K, Opoku-Anane J, Marusina AI, Coligan JE, Borrego F. Source. Naive CD8+ T cells costimulatory receptor for human cutting edge: NKG2D is a costimulatory receptor for human naive CD8+ T cells. J Immunol. 2005;174:4480–4.
Cerboni C, Ardolino M, Santoni A, Zingoni A. Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells. Blood. 2009;113:2955–64.
Maccalli C, Scaramuzza S, Permiani G. TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors. Cancer Immunol Immunother. 2009;58:801–8.
von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol. 2003;3:867–78.
Kabelitz D, Wesch D, He W. Perspectives of gamma delta T cells in tumor immunology. Cancer Res. 2007;67:5–8.
Parmiani G. Tumor-infiltrating T, cells-friend or foe of neoplastic cells? N Engl J Med. 2005;353:2640–1.
Mazzoccoli G, Balzanelli M, Giuliani A, De Cata A, La Viola M, Carella AM, Bianco G, Tarquini R. Lymphocyte subpopulations anomalies in lung cancer patients and relationship to the stage of disease. In Vivo. 1999;13(3):205–9.
Mazzoccoli G, Muscarella LA, Fazio VM, Piepoli A, Pazienza V, Dagostino MP, Giuliani F, Polyakova VO, Kvetnoy I. Antiphase signalling in the neuroendocrine-immune system in healthy humans. Biomed Pharmacother. 2011;65(4):275–9.
Dimitrov S, Benedict C, Heutling D. Cortisol and epinephrine control opposing circadian rhythms in T cell subsets. Blood. 2009;113:5134–43.
Lange T, Dimitrov S, Born J. Effects of sleep and circadian rhythm on the human immune system. Ann N Y Acad Sci. 2010;1193:48–59.
Mazzoccoli G, De Cata A, Greco A, Carughi S, Giuliani F, Tarquini R. Circadian rhythmicity of lymphocyte subpopulations and relationship with neuro-endocrine system. J Biol Regul Homeost Agents. 2010;24(3):341–50.
Dimitrov S, Lange T, Born J. Selective mobilization of cytotoxic leukocytes by epinephrine. J Immunol. 2010;184(1):503–11.
Bollinger T, Bollinger A, Naujoks J, Lange T, Solbach W. The influence of regulatory T cells and diurnal hormone rhythms on T helper cell activity. Immunology. 2010;131(4):488–500.
Mazzoccoli G, Giuliani A, Carughi S, De Cata A, Puzzolante F, La Viola M, Urbano N, Perfetto F, Tarquini R. The hypothalamic-pituitary-thyroid axis and melatonin in humans: possible interactions in the control of body temperature. Neuro Endocrinol Lett. 2004;25(5):368–72.
Mazzoccoli G, Carughi S, Sperandeo M, Pazienza V, Giuliani F, Tarquini R. Neuro-endocrine correlations of hypothalamic-pituitary-thyroid axis in healthy humans. J Biol Regul Homeost Agents. 2011;25(2):249–57.
Mazzoccoli G, Giuliani F, Inglese M, Marzulli N, Dagostino MP, De Cata A, Greco A, Carughi S, Tarquini R. Chronobiologic study of the GH-IGF1 axis and the aging immune system. J Appl Biomed. 2010;8(4):213–26.
Mazzoccoli G, Sothern RB, Pazienza V, Piepoli A, Muscarella LA, Giuliani F. Chronobiologic study of neuro-endocrine axis hormone sequence signalling in healthy men. Biomed Aging Pathol. 2011;1:129–37.
Logan RW, Zhang C, Murugan S, O’Connell S, Levitt D, Rosenwasser AM, Sarkar DK. Chronic shift-lag alters the circadian clock of NK cells and promotes lung cancer growth in rats. J Immunol. 2012;188(6):2583–91.
Mazzoccoli G, Grilli M, Carughi S, Puzzolante F, De Cata A, La Viola M, Giuliani A, Urbano N, Tarquini R, Perfetto F. Immune system alterations in lung cancer patients. Int J Immunopathol Pharmacol. 2003;16(2):167–74.
Mazzoccoli G, Fontana A, Copetti M, Pellegrini F, Piepoli A, Muscarella LA, Pazienza V, Giuliani F, Tarquini R. Stage dependent destructuration of neuro-endocrine-immune system components in lung cancer patients. Biomed Pharmacother. 2011;65(1):69–76.
Mazzoccoli G, Vendemiale G, De Cata A, Carughi S, Tarquini R. Altered time structure of neuro-endocrine-immune system function in lung cancer patients. BMC Cancer. 2010;10:314.
Mazzoccoli G, Sothern RB, Parrella P, Muscarella LA, Fazio VM, Giuliani F, Polyakova V, Kvetnoy IM. Comparison of circadian characteristics for cytotoxic lymphocyte subsets in non-small cell lung cancer patients versus controls. Clin Exp Med. 2012;12:181–94.
Mazzoccoli G, Tarquini R, Durfort T, Francois JC. Chronodisruption in lung cancer and possible therapeutic approaches. Biomed Pharmacother. 2011;65(7):500–8.
Martin-Orozco N, Muranski P, Chung Y, Yang XO, Yamazaki T, Lu S, Hwu P, Restifo NP, Overwijk WW, Dong C. T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity. 2009;31(5):787–98.
Jetten AM. Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal. 2009;7:e003.
Solt LA, Kumar N, Nuhant P, Wang Y, Lauer JL, Liu J, Istrate MA, Kamenecka TM, Roush WR, Vidović D, Schürer SC, Xu J, Wagoner G, Drew PD, Griffin PR, Burris TP. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature. 2011;472:491–4.
Lardone PJ, Guerrero JM, Fernández-Santos JM, Rubio A, Martín-Lacave I, Carrillo-Vico A. Melatonin synthesized by T lymphocytes as a ligand of the retinoic acid-related orphan receptor. J Pineal Res. 2011;51:454–62.
Hu S, Shen G, Yin S, Xu W, Hu B. Melatonin and tryptophan circadian profiles in patients with advanced non-small cell lung cancer. Adv Ther. 2009;26(9):886–92.
Mazzoccoli G, Carughi S, De Cata A, La Viola M, Giuliani A, Tarquini R, Perfetto F. Neuroendocrine alterations in lung cancer patients. Neuro Endocrinol Lett. 2003;24(1–2):77–82.
Mazzoccoli G, Carughi S, De Cata A, La Viola M, Vendemiale G. Melatonin and cortisol serum levels in lung cancer patients at different stages of disease. Med Sci Monit. 2005;11(6):CR284–8.
Mazzoccoli G, Francavilla M, De Petris MP, Giuliani F, Sothern RB. Comparison of whole body circadian phase evaluated from melatonin and cortisol secretion profiles in healthy humans. Biomed Aging Pathol. 2011;1:112–22.
Mazzoccoli G, Giuliani F, Sothern RB. Determination of whole body circadian phase in lung cancer patients: melatonin vs. cortisol. Cancer Epidemiol. 2012;36(1):e46–53.
Mazzoccoli G, Giuliani A, Bianco G, De Cata A, Balzanelli M, Carella AM, La Viola M, Tarquini R. Decreased serum levels of insulin-like growth factor (IGF)-I in patients with lung cancer: temporal relationship with growth hormone (GH) levels. Anticancer Res. 1999;19(2B):1397–9.
Mazzoccoli G, Sothern RB, Pazienza V, Piepoli A, Muscarella LA, Giuliani F, Tarquini R. Circadian aspects of growth hormone-insulin-like growth factor axis function in patients with lung cancer. Clin Lung Cancer. 2012;13(1):68–74.
Mazzoccoli G, Pazienza V, Piepoli A, Muscarella LA, Giuliani F, Sothern RB. Alteration of hypothalamic-pituitary-thyroid axis function in non-small-cell lung cancer patients. Integr Cancer Ther. 2012;11(4):327–36.
Mazzoccoli G, Vinciguerra M, Muscarella LA, Fazio VM, Parrella P, Tarquini R. Hormone and cytokine circadian alteration in non small cell lung cancer patients. Int J Immunopathol Pharmacol. 2012;25(3):691–702.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer India
About this chapter
Cite this chapter
Mazzoccoli, G. (2014). Circadian Variation of Immune Mechanisms in Lung Cancer and the Role of Melatonin. In: Srinivasan, V., Brzezinski, A., Oter, S., Shillcutt, S. (eds) Melatonin and Melatonergic Drugs in Clinical Practice. Springer, New Delhi. https://doi.org/10.1007/978-81-322-0825-9_10
Download citation
DOI: https://doi.org/10.1007/978-81-322-0825-9_10
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-0824-2
Online ISBN: 978-81-322-0825-9
eBook Packages: MedicineMedicine (R0)